This project is designed to test
consumers’ understanding of quantitative information about
prescription drugs in direct-to-consumer (DTC) television ads. We
plan to conduct two 20-minute surveys with adults 60 years or
older. In Study 1, 900 participants will be randomly assigned to
one of nine test conditions. The conditions will vary by the type
of quantitative efficacy information (none, simple, or complex) and
the type of quantitative risk information (none, general, or
specific) in a DTC television ad for a fictitious prescription drug
to treat cataracts. In Study 2, 900 participants will be randomly
assigned to one of six test conditions. The conditions will vary by
the type of quantitative efficacy information (none, simple) and
the type of efficacy images in the ad (none, accurate improvement,
overstated improvement) in the same DTC ad as in Study 1.
Participants will watch the DTC television ad and then will
complete a questionnaire that will include measures of recall,
perceptions, attitudes, and intentions.
Ila Mizrachi 301 796-7726
ila.mizrachi@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.